SCHEMBL827786

SCHEMBL827786

C=CC[CH]CCC=C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1862567 0.81 TSHR (0.44)
SCHEMBL10766039 0.81
SCHEMBL10628467 0.80 TSHR (0.46)
SCHEMBL9821419 0.80
SCHEMBL11273036 0.78
SCHEMBL148792 0.76
SCHEMBL14777661 0.76
SCHEMBL11519589 0.76
SCHEMBL23732 0.76
SCHEMBL8852489 0.76 TSHR (0.54)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11807664-B2 Method for producing cyclic organic compound CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2023-11-07 US disclosed
US-20210147475-A1 METHOD FOR PRODUCING CYCLIC ORGANIC COMPOUND CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2021-05-20 US disclosed
EP-3623378-A1 METHOD FOR PRODUCING CYCLIC ORGANIC COMPOUND Chugai Seiyaku Kabushiki Kaisha (JP) 2020-03-18 EP disclosed
US-9765058-B2 Substituted benzylpyrazoles BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-09-19 US disclosed
US-9556187-B2 Substituted pyrrolo[3′,2′:5,6]pyrido[4,3-d]pyrimidines and JAK inhibitors comprising the same NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2017-01-31 US disclosed
EP-3112370-A1 TRICYCLIC HETEROCYCLIC COMPOUNDS AND JAK INHIBITORS Nissan Chemical Industries, Ltd. (JP) 2017-01-04 EP disclosed
US-9403798-B2 Triazinone compound and T-type calcium channel inhibitor NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2016-08-02 US disclosed
US-20160168130-A1 HETEROARYL SUBSTITUTED PYRAZOLES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2016-06-16 US disclosed
US-20160151370-A1 Substituted Benzylpyrazoles BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2016-06-02 US disclosed
US-20160145239-A1 DIAMINOHETEROARYL SUBSTITUTED PYRAZOLES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2016-05-26 US disclosed
US-20100168430-A1 MULTIKINASE INHIBITOR CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2010-07-01 US disclosed
US-20090247524-A1 HSP90 Inhibitor CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2009-10-01 US disclosed
US-20090030195-A1 1-(2H)-ISOQUINOLONE DERIVATIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2009-01-29 US disclosed
EP-1854792-A1 1-(2H)-ISOQUINOLONE DERIVATIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2007-11-14 EP disclosed
US-20070185160-A1 1-(2H)-isoquinolone derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2007-08-09 US disclosed
EP-1724262-A1 1-(2H)-ISOQUINOLONE DERIVATIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2006-11-22 EP disclosed
US-20060217434-A1 Remedy for viral disease CHUGAI SEIYAKU KABUSHIKI KAISHA 2006-09-28 US disclosed
EP-0940405-B1 Organosilicon compounds containing alkenyl groups WACKER CHEMIE GMBH (DE) 2002-03-13 EP disclosed
US-6252101-B1 ADDITION-CONDENSATION POLYMER WACKER-CHEMIE GMBH (DE) 2001-06-26 US disclosed
EP-0430194-A2 Aryl-alkyl-azoles substituted with many times unsaturated groups, process for their preparation and their use HOECHST AKTIENGESELLSCHAFT (DE) 1991-06-05 EP disclosed